Showing results (101-110 of 113) with videos related to
Sort By:
Pageof 12
Cancer Epidemiology|April 11, 2021
HPV DNA genotyping, HPV E6*I mRNA detection, and p16<sup>INK4a</sup>/Ki-67 staining in Belgian head and neck cancer patient specimens, collected within the HPV-AHEAD studyCindy Simoens, Ivana Gorbaslieva, Tarik Gheit, et al.International Journal of Cancer|June 8, 2026
Clinical Validation of Four Point-of-Care High-Risk HPV Assays, Including Two Reduced-Valency Assays, for Cervical Cancer Screening in Low-Resource SettingsNeerja Bhatla, MaryLuz Rol, Seema Singhal, et al.Journal of the National Cancer Institute. Monographs|November 12, 2024
A prospective cohort study comparing efficacy of 1 dose of quadrivalent human papillomavirus vaccine to 2 and 3 doses at an average follow up of 12 years postvaccinationSylla G Malvi, Pulikkottil O Esmy, Richard Muwonge, et al.Human Vaccines & Immunotherapeutics|December 11, 2023
Impact of age at vaccination and cervical HPV infection status on binding and neutralizing antibody titers at 10 years after receiving single or higher doses of quadrivalent HPV vaccineNeerja Bhatla, Richard Muwonge, Sylla G Malvi, et al.Plos One|December 29, 2020
Acquisition, prevalence and clearance of type-specific human papillomavirus infections in young sexually active Indian women: A community-based multicentric cohort studyRichard Muwonge, Partha Basu, Tarik Gheit, et al.The Lancet. Oncology|October 11, 2021
Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort studyPartha Basu, Sylla G Malvi, Smita Joshi, et al.Cancers|December 2, 2020
Role of Human Papillomavirus Infection in Head and Neck Cancer in Italy: The HPV-AHEAD StudyMarta Tagliabue, Marisa Mena, Fausto Maffini, et al.Vaccine|November 29, 2022
Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccinationSmita Joshi, Devasena Anantharaman, Richard Muwonge, et al.Papillomavirus Research (Amsterdam, Netherlands)|March 27, 2018
Are two doses of human papillomavirus vaccine sufficient for girls aged 15-18 years? Results from a cohort study in IndiaNeerja Bhatla, Bhagwan M Nene, Smita Joshi, et al.Frontiers in Medicine|December 5, 2022
Implementing HPV testing in 9 Latin American countries: The laboratory perspective as observed in the ESTAMPA studyMary Luz Rol, María Alejandra Picconi, Annabelle Ferrera, et al.Pageof 12